| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00278585 |
| P698 | PubMed publication ID | 2373132 |
| P2093 | author name string | B Lecocq | |
| P Jaillon | |||
| V Lecocq | |||
| G Cheymol | |||
| A Ferry | |||
| J M Poirier | |||
| P2860 | cites work | Cardiovascular pharmacology of two new beta-adrenergic receptor antagonists | Q68714071 |
| Electrophysiologial and beta-receptor blocking effects of MJ 1999 on dog and rabbit cardiac tissue | Q68744945 | ||
| Quantitative liquid chromatographic determination of sotalol in human plasma | Q69767567 | ||
| [Electrophysiological effects of intravenous sotalol. Relation with plasma levels] | Q69948739 | ||
| Sotalol prolongation of the QTc interval in hypertensive patients | Q70368336 | ||
| Pharmacokinetic study of sotalol after 320 mg single oral doses in healthy adults using high performance liquid chromatography (author's transl) | Q70959252 | ||
| Pharmacokinetic study of sotalol administered intravenously to healthy men. Application of high performance liquid chromatography (author's transl) | Q70959257 | ||
| Stereoselective clearance and distribution of intravenous propranolol | Q71388555 | ||
| Antiarrhythmic activity of the dextro- and levorotatory isomers of 4-(2-isopropylamino-1-hydroxyethyl) methanesulfonanilide (MJ 1999) | Q72152544 | ||
| Antiarrhythmic and antifibrillatory actions of the levo- and dextrorotatory isomers of sotalol | Q72381787 | ||
| Pharmacokinetics and pharmacodynamics in young normal and elderly hypertensive subjects: a study using sotalol as a model drug | Q72418011 | ||
| Prolongation of the human cardiac monophasic action potential by sotalol | Q72538644 | ||
| A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474 | Q34234794 | ||
| Sotalol-induced delayed ventricular repolarization in man. | Q34717403 | ||
| Acute prolongation of myocardial refractoriness by sotalol | Q41300596 | ||
| Plasma clearance of propranolol and sotalol and hepatic drug-metabolizing enzyme activity | Q41677038 | ||
| Stereoselective binding of propranolol enantiomers to human alpha 1-acid glycoprotein and human plasma | Q41940414 | ||
| Pharmacokinetics of (+)-, (-)- and (+/-)-verapamil after intravenous administration | Q42532060 | ||
| The effect of end-stage renal failure and haemodialysis on the elimination kinetics of sotalol | Q43255348 | ||
| Human pharmacokinetics of sotalol. | Q43704312 | ||
| Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists. | Q52760633 | ||
| Pharmacokinetics of the -adrenergic blocker sotalol in dogs. | Q52950933 | ||
| Studies on the Pharmacokinetics and Pharmacodynamics of the Beta-Adrenergic Blocking Agent Sotalol in Normal Man | Q66943506 | ||
| The acute cardiac electrophysiological effects of intravenous sotalol hydrochloride | Q66971874 | ||
| P433 | issue | 6 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| P304 | page(s) | 579-582 | |
| P577 | publication date | 1990-01-01 | |
| P1433 | published in | European Journal of Clinical Pharmacology | Q1376707 |
| P1476 | title | The pharmacokinetics of d-sotalol and d,l-sotalol in healthy volunteers | |
| P478 | volume | 38 |
| Q36857602 | A cardiovascular monitoring system used in conscious cynomolgus monkeys for regulatory safety pharmacology. Part 2: Pharmacological validation. |
| Q35803087 | Adverse effects of a single dose of (+)-sotalol in patients with mild stable asthma |
| Q71907172 | Hemodynamic effects of the class III antiarrhythmic drug, d-sotalol, in patients with congestive heart failure |
| Q46813227 | Interaction of class III antiarrhythmic drugs with muscarinic M2 and M3 receptors: radioligand binding and functional studies |
| Q40438889 | Pharmacodynamic, Pharmacokinetic and Antiarrhythmic Properties of d-Sotalol, the Dextro-Isomer of Sotalol |
| Q41975490 | Physiologically based pharmacokinetic models in the prediction of oral drug exposure over the entire pediatric age range-sotalol as a model drug |
| Q40385556 | Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias |
| Q34345475 | Stereoselective disposition of (+/-)-sotalol at steady-state conditions |
| Q67852164 | Stereospecific high-performance liquid chromatographic assay of sotalol in plasma |
| Q42780616 | Therapeutic drug monitoring: antiarrhythmic drugs |
| Q53127041 | Using Physiologically Based Pharmacokinetic (PBPK) Modelling to Gain Insights into the Effect of Physiological Factors on Oral Absorption in Paediatric Populations. |
Search more.